retatrutide lilly Eli Lilly's retatrutide sets new
Description
Nowell J, Blunt E, Gupta D, Edison P (2023) Antidiabetic agents as a novel treatment for Alzheimers and Parkinsons disease
These shifts drive both weight regain and a loss of glycemic control
In 2021, after extensive clinical trials, the FDA approved semaglutide for weight loss under the brand name Wegovy
For manufacturers, the focus is less about choosing between formats, and more about building platforms that can scale intelligently, adapt to future modalities, and remain compliant under increasing regulatory scrutiny
J Clin Invest (1984) 73:78593
46 (2), e118e125
